Clinical trial
A Prospective Standardized Assessment of People With Cystic Fibrosis and Non-tuberculosis Mycobacteria Pulmonary Disease Undergoing Treatment With Mycobacteriophage (POSTSTAMP)
NCT06262282 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Standardized Assessment of People With Cystic Fibrosis and Non-tuberculosis Mycobacteria Pulmonary Disease Undergoing Treatment With Mycobacteriophage (POSTSTAMP)
- Lead sponsor
- National Jewish Health
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- February 5, 2024
- Completion date
- December 31, 2028
- Enrollment
- 10 (estimated)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
cystic fibrosis, mycobacterium infections, mycobacterium; pulmonary, nontuberculous mycobacterial lung disease, nontuberculous mycobacterium infection